Published: Thursday 29 February 1996

An antiviral drug, which was recently approved by the US Food and Drug Administration for treating AIDS, has been found to have the potential to treat chronic hepatitis B infection too. Lamivudine, or 3TC, .the drug manufactured by the Glaxo Wellcome group under the brand name Epivir, is reported to have cured 20 hepatitis B patients at the Massachusettes General Hospital in the US.

Hepatitis B is a kind of liver disease usually transmitted through sexual contact or contaminated needles. So far, the only treatment has been interferon (the protein released by the body's immune system in response to an invading virus). Interferon injections, however, have side effects that the new drug hardly has.

Subscribe to Daily Newsletter :

Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.